Cost reductions associated with a quality improvement initiative for patients with ST-elevation myocardial infarction

Chad E Darling1, Craig S Smith, Jiaoyuan E Sun

  • 1University of Massachusetts Medical School, Worcester, MA, USA. Chad.Darling@umassmed.edu

Insights

Implementing a quality improvement program to reduce door-to-balloon times for ST-elevation myocardial infarction (STEMI) patients significantly lowered inpatient care costs. This initiative streamlined cardiac catheterization, improving efficiency and reducing overall expenses.

Area of Science:

  • Cardiology
  • Healthcare Quality Improvement
  • Health Economics

Background:

  • ST-elevation myocardial infarction (STEMI) management focuses on reducing door-to-balloon (DTB) times.
  • Shorter DTB times correlate with reduced mortality and length of stay (LOS) for STEMI patients.
  • Limited research exists on the cost implications of DTB time reduction initiatives.

Purpose of the Study:

  • To evaluate the impact of a STEMI quality improvement (QI) program on patient care costs.
  • To assess changes in hospital costs associated with STEMI care following the implementation of a Cardiac Alert Team (CAT) initiative.

Main Methods:

  • A QI program (CAT) was implemented in July 2006 at a tertiary care center.
  • Hospital costs and clinical outcomes for STEMI patients were analyzed across three cohorts: pre-CAT (Jan 2005-Jun 2006) and two post-CAT periods (Oct 2007-Sep 2011).
  • Adjusted hospital costs were compared between the cohorts.

Main Results:

  • Average direct inpatient costs for STEMI care decreased by 9.1% and 7.3% in the post-CAT periods compared to pre-CAT ($14,634).
  • Mean DTB times significantly reduced from 91 minutes pre-CAT to 55-61 minutes post-CAT (p < .001).
  • Length of stay (LOS) showed a nonsignificant reduction from 4.4 days to 3.6 days (p = .11).

Conclusions:

  • A QI program targeting DTB time reduction for STEMI patients also resulted in significant cost savings.
  • The primary cost reduction was observed in cardiac catheterization, attributed to care standardization and efficiency identification.
  • QI initiatives for STEMI care can yield both clinical benefits and economic advantages.
Abstract

Related Concept Videos

Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Angina V: Nursing Management01:20

Angina V: Nursing Management

Angina, a symptom of myocardial ischemia, requires a structured nursing management approach to ensure effective care and prevent complications like myocardial infarction. Comprehensive nursing care involves assessing, diagnosing, planning, implementing interventions, and evaluating outcomes, all tailored to the individual patient's needs.Patient AssessmentNursing assessment begins with a detailed subjective evaluation of symptoms, which typically include chest pain or pressure radiating to the...
Angina IV: Management01:26

Angina IV: Management

IntroductionThe management of angina requires a comprehensive approach that includes pharmacological therapies, medical procedures, and lifestyle modifications.Pharmacological TherapiesAntiplatelet agents, such as aspirin, clopidogrel, prasugrel, and ticagrelor, play a pivotal role in preventing thrombus formation in patients with angina. These medications inhibit platelet aggregation and reduce the likelihood of myocardial infarction and other cardiovascular events.Anticoagulants, including...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...